Company: EVGN
Filing Date: 2025-03-27
Form Type: 20-F
Source: 0001178913-25-001092
Chunk: 22

Company: Evogene Ltd.
Filing Date: 2025-03-27
Form: 20-F
Item: Item 3
Chunk 22
---
., Rnway Ltd., Wonder Veggies Ltd., Seekwell Ltd. and Karme Yosef Winery. Dr. Shoseyov
is a faculty member of The Hebrew University of Jerusalem, Israel, where he conducts research in plant molecular biology protein engineering
and nano-biotechnology. His group’s focus is on Bio-Inspired Nanocomposite materials. He has authored or co-authored more than 350
scientific publications and is the inventor or co-inventor of 103 patents. Dr. Shoseyov is a TED speaker and a co-owner and winemaker
of Bravdo winery. Dr. Shoseyov received the Outstanding Scientist Polak Award for 2002, the 1999 and 2010 Kay Award for Innovative and
Applied Research, the 2012 Israel Prime Minister Citation for Entrepreneurship and Innovation, and the 2018 Presidential Award for his
contribution to the Economy and Society of Israel. Dr. Shoseyov holds a B. Sc., an M. Sc. and a Ph. D. from The Hebrew University of Jerusalem,
Israel.

81

Arrangements for Election of Directors and Members of Management;
Family Relationships

There are no arrangements or understandings with major shareholders,
customers, suppliers or others related to the election of our board of directors or the appointment of members of our senior management.
There are furthermore no family relationships among any directors or members of our senior management.

B. Compensation

Aggregate and Individual Compensation of Officers and Directors

The aggregate compensation, including non-cash share-based compensation
(consisting of expenses related to option grants), accrued by us in respect of the year ended December 31, 2024 to all persons who served
as directors and/or executive officers during that year, was approximately $3.8 million. That amount includes approximately $0.1 million
of gross compensation set aside or accrued for executive officers for purposes of pension, severance, retirement, car, phone or similar
benefits or expenses, but does not include business travel, relocation, professional and business association dues and expenses reimbursed
to executive officers, and other expenses commonly reimbursed by companies in Israel. These amounts include the partial-year compensation
paid to seven executive officers, who served in their positions over the course of 2024 and whose employment as executive officers either
was terminated or has commenced during 2024.

During 2024, we granted our executive officers and directors an
aggregate amount of 152,600